chrisvoncsefalvay/vaers-outcomes huggingface dataset:
chest pain; upset stomach; sore throat; stuffy head; fever , temperature of 102; achy all over; chills; tired; headache; sore arm; This spontaneous case was reported by a consumer and describes the occurrence of CHEST PAIN (chest pain), ABDOMINAL DISCOMFORT (upset stomach), OROPHARYNGEAL PAIN (sore throat), HEAD DISCOMFORT (stuffy head) and PYREXIA (fever , temperature of 102) in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. DO1A21A and 007B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Lupus-like syndrome and Fibromyalgia. Concomitant products included VENLAFAXINE, COLECALCIFEROL (CHOLECALCIFER EG), METOPROLOL, DIPHENHYDRAMINE, FUROSEMIDE, NORTRIPTYLINE, MAGNESIUM OXIDE, POTASSIUM CHLORIDE, ALPHA LIPOIC ACID, BIFIDOBACTERIUM INFANTIS (ALIGN), SALBUTAMOL (ALBUTEROL HFA), FLECAINIDE ACETATE, ROSUVASTATIN, EZETIMIBE, CALCIUM CARBONATE, VITAMIN D NOS (CALCIUM + VIT D), BUPROPION, BENZTROPINE MESYLATE, OMEPRAZOLE, RIBOFLAVIN, LEVOTHYROXINE, LORATADINE, VALPROATE SEMISODIUM (DIVALPROEX), L-LYSINE HCL and PIROXICAM for an unknown indication.   On 24-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 24-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 25-Mar-2021, the patient experienced CHEST PAIN (chest pain), ABDOMINAL DISCOMFORT (upset stomach), OROPHARYNGEAL PAIN (sore throat), HEAD DISCOMFORT (stuffy head), PYREXIA (fever , temperature of 102), MYALGIA (achy all over), CHILLS (chills), FATIGUE (tired), HEADACHE (headache) and VACCINATION SITE PAIN (sore arm). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL A) at an unspecified dose and frequency; DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN, PARACETAMOL, PSEUDOEPHEDRINE HYDROCHLORIDE (DAYQUIL) at an unspecified dose and frequency; DEXTROMETHORPHAN HYDROBROMIDE, DOXYLAMINE SUCCINATE, EPHEDRINE SULFATE, ETHANOL, PARACETAMOL (NYQUIL) at an unspecified dose and frequency and PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, CHEST PAIN (chest pain), ABDOMINAL DISCOMFORT (upset stomach), OROPHARYNGEAL PAIN (sore throat), HEAD DISCOMFORT (stuffy head), PYREXIA (fever , temperature of 102), MYALGIA (achy all over), CHILLS (chills), FATIGUE (tired), HEADACHE (headache) and VACCINATION SITE PAIN (sore arm) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 25-Mar-2021, Body temperature: 102 (High) 102.         The patient stated that she was okay on and off.   This case was linked to MOD-2021-060540 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 12-May-2021: Follow-up information received on 12 May 2021 included email address of reporter.
Prior to receiving vaccine, vaccinator stated patient had increased ?anxiety? making statements such as ?I?m going to die! This vaccine is going to kill me!? Immediately after receiving vaccine (less than 3 seconds) patient slumped down in chair, writer to the patient, patient stating  ?I can?t breathe, its going dark, I?m going to die! What about my daughter!? Writer and vaccinator attempted to talk patient down, ineffective. Patient V/S 100/60, 66-HR, 98%-O2, 22-Resp.  Patient became limp in chair, unresponsive, episode of urinary incontinence, EMS activated. ~90 seconds into episode patient regained consciousness, A&Ox4, stating ?I?m back. I?m back.? Patient reports this last happened to her ?in college?. Patient also states ?my doctor told me not to get the vaccine, to wait until August since I have Lyme Disease.? Patient to ED with EMS.
Patient states that the following morning he began to experience side effects of Chills, Fatigue, Body Aches, and Dizziness.  After 5 days with no relief, he proceeded to urgent care and spoke with his PCP.  They have tested him with both a Rapid and a regular COVID test and both were negative.  He has never had a fever.  They have tried various treatments, but he is still  having these symptoms.
Narrative:  Per 5/12/21 TELEPHONE NOTE, adverse vaccine reaction occurred for approximately 6 days following initial documentation in Patient's chart. No further complications documented following caregiver reported resolution.
Normal labor and delivery on 11/26/2021. ED visit on 12/2/2021 - for viral symptoms; resolved. ED visit and hospital admission within 6 weeks of receiving the COVID vaccine.
Starting with August 1998, he gradually showed symptoms of autism. Started with chewing finger from blister (ER visit) on 9/27/98 when finger was bloody and passed out on 10/27/98. Dx'd with autism.
Patient received 1st dose 10/7. ON 11/1 she started with sore throat. Persisted, sought medical care 11/3, 11/10, 11/22 for this. 11/22 it is noted she has lesions on her tongue as well. Infectious work up negative. Symptoms improve with decahedron. 11/24 she receives 2nd dose of Pfizer. 11/28 seeks ED care for recurrent sore throat and 2 days new vaginal pain. Seeks care PCP 12/2 for vaginal ulcerations. STI work up negative including HSV, HIV, RPR. Seeks ED care 12/3 for sore throat and tongue ulcerations.Seeks ED care 12/7 for worsening oral/throat ulcerations, hospitalized.Extensive work-up negative for infection. Seeks ED care 12/19, hospitalized, diagnosed with Bechet's disease.
This spontaneous report was received from an osteopathic physician referring to an unspecified number of patients of unknown age and gender. The patients' medical history, concurrent conditions and concomitant therapies were not reported. On unknown dates (reported as at an unspecified time in the past), the patients were vaccinated with unspecified doses of VAQTA (strength, dose, route, anatomical location, lot number and expiration date were not provided), for prophylaxis. It was reported that the vaccinations were administered according to series schedule. On an unknown date, the patients were tested for titers to VAQTA and the patients had negative titers. It was unknown if the patients received treatment. No adverse effects and no product quality complaint were reported. At the time of reporting, the outcome of hepatitis A antibody negative was unknown. The causal relationship between the hepatitis A antibody negative and VAQTA was not reported. Additional information has been requested.
4 inch red edematous area over left tricept. Warm to touch and no pruritus. First appeared as small welt 24hrs after administration. Increased in diameter at 36hrs. Benadryl given. Site continues to appear warm, red, and slightly edematous after 48hrs. Client remains afebrile.
multifocal stinging sensations in all 4 extremities, mainly in feet & hands, getting a couple hundred per day;first sensation rt race-rt hand, lt hand & feet;pt noted 5th rt finger numbness;
Pt received Var # 1 right thigh no complications. Pt received DTaP #4 left thigh IM and within 24 hours had local reaction of erythema and induration. Extended across entire anterior thigh. Started to improve after 48 hours.
Initially headache, and sore arm at injection site. Only sore on contact and not too bad. Fatigue and loss of muscle strength (I am a hard core cyclist), not detectable during normal activities. A week later it persists. On the fourth evening, I could not stay asleep. As soon as I would drop off I would dream. It would be a violent encounter. I would physically strike out and I would wake up.
FELT BETTER/MORE ENERGY/ ABLE TO FUNCTION/ WEIGHT GAIN/ INCREASED APPETITE/BLOOD CLOTS IN LUNGS AND IN LEFT ARM GONE; This spontaneous report received from a patient concerned a 62 year old male. The patient's height, and weight were not reported. The patient's concurrent conditions included t-cell lymphoma in both lungs, inoperable pelvic tumor maybe be prostate, blood clots in lungs, and blood clots in left arm. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1806609, expiry: 09-JUN-2021) dose was not reported, administered on 30-MAR-2021 for prophylactic vaccination. Concomitant medications included rivaroxaban for blood clot in left arm, and blood clot in lung. On 09-APR-2021, the subject experienced felt better/more energy/ able to function/ weight gain/ increased appetite/blood clots in lungs and in left arm gone. Laboratory data (dates unspecified) included: Blood test (NR: not provided) Not reported, and CT scan (NR: not provided) Not reported. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of felt better/more energy/ able to function/ weight gain/ increased appetite/blood clots in lungs and in left arm gone was not reported. This report was non-serious.
Patient went to urgent care that evening with fever, chills, sweats, body aches and swelling in both injection sites. He has since seen multiple doctors and is convinced his symptoms are a result of the vaccination.  He was told by the urgent care physician the two vaccines should not have been given together.  He states he was given steroid injections and has had 3 rounds of antibiotics.  He was diagnosed with bronchitis today.
Patient complained of rash/itching all over. Patient also complained of nausea and dizziness. Patient denies any fever or vomiting. Patient reports symptoms started the evening after getting the injection. Per patient symptoms lasted one week. Patient did not notify us right away.
Temperature was up a couple of degrees; rash at the injection site.The rash is approximately 2" X 3" in size and is not raised or bumpy.; Left arm is also swelling; sore throat; Stuffy nose; Feverish; feeling "achy"; Headache; Tenderness in her left arm; This spontaneous case was reported by a consumer and describes the occurrence of OROPHARYNGEAL PAIN (sore throat), NASAL CONGESTION (Stuffy nose), BODY TEMPERATURE INCREASED (Temperature was up a couple of degrees), PYREXIA (Feverish) and MYALGIA (feeling "achy") in a 62-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 022M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Previously administered products included for an unreported indication: FLU VACCINE VII. Concomitant products included MULTIVITAMINS [VITAMINS NOS] for an unknown indication.    On 03-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-Mar-2021, the patient experienced INJECTION SITE PAIN (Tenderness in her left arm). On 10-Mar-2021, the patient experienced OROPHARYNGEAL PAIN (sore throat), NASAL CONGESTION (Stuffy nose), PYREXIA (Feverish), MYALGIA (feeling "achy") and HEADACHE (Headache). On 12-Mar-2021, the patient experienced BODY TEMPERATURE INCREASED (Temperature was up a couple of degrees), INJECTION SITE RASH (rash at the injection site.The rash is approximately 2" X 3" in size and is not raised or bumpy.) and INJECTION SITE SWELLING (Left arm is also swelling). The patient was treated with IBUPROFEN (ADVIL [IBUPROFEN]) ongoing since an unknown date at an unspecified dose and frequency. On 05-Mar-2021, INJECTION SITE PAIN (Tenderness in her left arm) had resolved. At the time of the report, OROPHARYNGEAL PAIN (sore throat), NASAL CONGESTION (Stuffy nose), BODY TEMPERATURE INCREASED (Temperature was up a couple of degrees), PYREXIA (Feverish), MYALGIA (feeling "achy"), HEADACHE (Headache), INJECTION SITE RASH (rash at the injection site.The rash is approximately 2" X 3" in size and is not raised or bumpy.) and INJECTION SITE SWELLING (Left arm is also swelling) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Patient increased fluid intake.   Most recent FOLLOW-UP information incorporated above includes: On 30-Mar-2021: NNI
This spontaneous report was received from a health professional (nurse) refers to a 1 year old patient. Pertinent medical history and reactions/allergies were unspecified. On 13-MAY-2015 the patient received PROQUAD (Merck), .5 ml, subcutaneous and VARIVAX (Merck) (inappropriate schedule of drug administration). Nurse also reported that the patient received PROQUAD (Merck), when he/she should have received M-M-R II (wrong drug administered). No adverse effects were reported. Additional information has been requested.
evening of vax pt devel redness @ inject site. 5/13 devel induration size of egg. seen @ clinic w/mild redness & warmth to touch.  seen by regular MD, temp ranging from 99-100f was dx w/tonsillitis & given ceptin & cataflan
Day 2 and Day 3 - nausea, vertigo, dizziness, anxiety, trembling Day 3 and Day 4 - head ache, nausea, heart palpitations, elevated blood pressure ( 165/81 pulse 85 where the normal is 130's/70's pulse 60's) , night terrors
EXTREME BODY ACHES, CHILLS, FEVER, DEHYDRATED, HEADACHE
Reinfection and breakthrough infection. Pt contracted COVID-19 on 11/1/2020 and again on 5/10/2021, 3 months post vaccination. Pt is currently hospitalized for COVID-19 at .
pt sitting on table to receive vax syncope, convuls 7-10min post vax
Immediate partial paralysis to limb which has resolved. Seizures, fevers, fainting episodes, muscle burning, fatigue, migraines, cramps, speech impairment, mood disorder, school days missed for feeling nauseated or migraines. Some of these symptoms are still happening, mostly muscle problems, fatigue and speech issues, and mood swings.
tested + for covid on     10-7-2022                                          deceased 4-24-23  had three moderna vaccines
A red strip across the left arm , which was the injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE ERYTHEMA (A red strip across the left arm , which was the injection site) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 19-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 04-Feb-2021, the patient experienced VACCINATION SITE ERYTHEMA (A red strip across the left arm , which was the injection site). At the time of the report, VACCINATION SITE ERYTHEMA (A red strip across the left arm , which was the injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant product use was not provided by the reporter.  No treatment information was provided.
arm is a mess; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A patient (no qualifiers provided) received rsv vaccine prot.subunit pref 2v (ABRYSVO), on 20Sep2023 as dose number unknown, single (Batch/Lot number: unknown) for immunisation; for immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: LIMB DISCOMFORT (non-serious) with onset 2023, outcome "not recovered", described as "arm is a mess".  The information on the batch/lot number for rsv vaccine prot.subunit pref 2v, rsv vaccine prot.subunit pref 2v  has been requested and will be submitted if and when received.
first 24 hours: fever, headache, lethargy, abdominal pain, nausea, constant leg pain symptoms continued for five days, then largely subsided all returned except fever on 8th day, still continue
Patient reports experiencing severe pain along the length of her spine for approximately 1 month following her vaccination. She states that she took pain relievers with some reduction in pain, but the pain continued to persist to some degree for a total duration of 1 month. Patient states that she experienced a similar type of spine pain following the administration of her first dose of the Moderna COVID-19 vaccine.
Vaccine administered on 03/09/2006.  Patient has had upper respiratory infection symptoms on week prior to Hepatitis A administration.  Erythema multiforme of both soles on 03/14/2006, diagnosis confirmed by doctor.
Presented with chest pain and emesis. Diagnosed with myopericarditis and admitted for observation and management with NSAIDs
I never have had joint pain and now I have swelling in my ankles and I have been told I have Psoriasis. I have been prescribed both prednisone and CELEBREX for treatment. I have joint pain in my fingers as well. A rheumatologist appointment is scheduled in July 2023.
Administer expired vaccine to patient after the manufacture date of expiration; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Administer expired vaccine to patient after the manufacture date of expiration) in a 75-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026C21A) for COVID-19 prophylaxis.     No Medical History information was reported.    On 25-Oct-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 25-Oct-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Administer expired vaccine to patient after the manufacture date of expiration). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Administer expired vaccine to patient after the manufacture date of expiration) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant product use was reported.  Date the vial was initially stored in the refrigerator was unknown. Expiration date was reported as 24-Oct-2021. The vial did not undergo any temperature excursions.  No treatment information was provided.    Most recent FOLLOW-UP information incorporated above includes: On 08-Jun-2022: Follow up received reporter address updated.
Racing heart beat up to 125 bpm.  Felt numbness on left arm Itching around mouth (lips) Dizzy
Fever 102 chills, muscle aches, overall malaria, inappetance day 2 muscle aches. Fever 99.9
Upper resp. symptoms prior to shot. Itchy throat 12 hours after shot, nasal drainage.
Client received 2 doses of Covid vaccine (Pfizer) in June 2021.  Developed symptoms of Covid  on 10/18 - nasal congestion, fatigue, weakness, myalgia, loss of taste and smell, fever, dizziness, chest heaviness with breathing,   Tested + with PCR on 10/18 and 10/25.  Treated with monoclonal antibody infusion at Hospital on 10/26.  Improvement in 24 hours noted.  Also treated with steroids and inhaler.
This is a spontaneous report from a contactable physician reporting on behalf of himself. This 73-year-old male patient received PREVNAR 13, via an unspecified route of administration at single dose in left deltoid on 28Apr2015. Medical history included blood pressure high from 2005 and ongoing, tachycardia from 2013 and ongoing, atrial fibrillation from 2013 and ongoing, osteoporosis from 2005 and ongoing. Concomitant medication included irbesartan 300 mg daily for high blood pressure, metoprolol 25 mg twice a day for hypertension and tachycardia, XARELTO 10 mg daily to prevent stroke and for atrial fibrillation, terazosin 10mg daily, RYTHMOL for atrial fibrillation. On 22May2015, the patient developed severe pain in shoulder with outcome of recovered. Also in 2015 (unspecified date), he experienced left arm partial paralysis, acute brachial neuritis or Parsonage-Turners syndrome with outcome of not recovered and pain on an unspecified date with outcome of unknown. The events were described as follows: About 4-5 weeks later the vaccination he developed Acute Brachial Neuritis or Parsonage-Turners Syndrome. The patient also had severe shoulder pain starting on 22May2015, for 5 days; the pain subsided and his arm was left partially paralyzed. The patient has not regained full use of his arm yet. The patient underwent lab tests and procedures, which included MRI of the neck and shoulder on 24Jul2015, that did not show any other cause or pathology. Electromyogram on 31Jul2015, showed the partial paralysis and weakness of the deltoid muscle. Nerve Conduction test on 31Jul2015 showed that he had a deficit in the nerves to the deltoid muscle.
Patient received DTaP immunization on 9/24/2002. Came in on 9/25/02 with 1cmx3cm red nodule, 4cmx5cm erythema, pink to site. No treatment at this time. Parent to observe site.
Heart palpitations; This spontaneous case was reported by a patient and describes the occurrence of PALPITATIONS (Heart palpitations) in an adult female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 prophylaxis.     Concurrent medical conditions included Supraventricular tachycardia.   On an unknown date, the patient received fourth dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced PALPITATIONS (Heart palpitations) (seriousness criterion hospitalization). At the time of the report, PALPITATIONS (Heart palpitations) had not resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   The patient was on heart medication. Patient was hospitalized after one of the Moderna Covid-19 vaccines. The patient did not specify after which dose that patient was hospitalized. After the first and second booster Moderna Covid-19 monovalent vaccines the patient had heart palpitations. The heart palpitations occurred after the first two booster doses. No treatment medication was provided. Company comment- This is a spontaneous case concerning an adult female patient of unknown age with medical history of supraventricular tachycardia who experienced the unexpected and serious (hospitalization) event of palpitations. Two doses of mRNA-1273 vaccine, given as booster doses of COVID vaccine schedule, were administered. Exact onset date of event and vaccination dates were not provided, hence latency cannot be assessed.  It was reported that after the first and second booster mRNA-1273 vaccines the patient had heart palpitations and was hospitalized after one of them (dose not specified). The patient said that she is on heart medication. No further details were provided for medical review. Medical history of supraventricular tachycardia remains as a confounder. The benefit-risk relationship of the mRNA-1273 vaccine is not affected by this report.   Reporter did not allow further contact
Sinus congetsion, aches, fever, chills, head ache, face pain, leg cramping, dizziness, weakness, eventual inability to walk or run in hips and quad muscles, sore arm at sight for 1 month now.
On 15, March 2021, I received my second Medrina shot. On March 26 I came down with a severe reaction to the shot. This was twelve days later. fever of 102.4 was the highest it got.I had Itching ,Chills and a severe rash that covered from my knees to the top of my head and back. On sunday the 28 of March I went to urgent care and was given a shot and Prednisone,Famotidine and Benadryl. I started taking this medication this morning. it seams to be working but very slow. is there anything else I can do or should I come in to the clinic.  also can I take any of the other shots?